We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
-19.73%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$11.1B
AUM Growth
-$2.57B
Cap. Flow
+$671M
Cap. Flow %
6.05%
Top 10 Hldgs %
19.98%
Holding
128
New
9
Increased
85
Reduced
25
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 24.88%
2 Technology 21.16%
3 Financials 14.01%
4 Consumer Staples 13.48%
5 Industrials 12.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDLA
26
DELISTED
Medallia, Inc.
MDLA
$149M 1.35%
7,455,235
+4,706,160
+171% +$127M
PANW icon
27
Palo Alto Networks
PANW
$256B
$146M 1.31%
5,329,590
+100,890
+2% +$3.52M
NTRS icon
28
Northern Trust
NTRS
$21.8B
$144M 1.3%
1,907,715
+64,500
+3% +$5.91M
LW icon
29
Lamb Weston
LW
$7.42B
$144M 1.29%
2,518,260
+228,505
+10% +$18.8M
ULTA icon
30
Ulta Beauty
ULTA
$21.8B
$142M 1.28%
808,785
+17,750
+2% +$4.43M
MZTI
31
The Marzetti Company
MZTI
$3.05B
$139M 1.25%
961,495
+194,710
+25% +$29.5M
MASI
32
DELISTED
Masimo
MASI
$137M 1.23%
773,350
-292,345
-27% -$50.1M
AAP icon
33
Advance Auto Parts
AAP
$3.53B
$134M 1.2%
1,431,560
+276,805
+24% +$35.9M
COO icon
34
Cooper Companies
COO
$14.2B
$133M 1.2%
1,931,320
+11,700
+0.6% +$953K
CMD
35
DELISTED
Cantel Medical Corporation
CMD
$132M 1.19%
3,669,710
+229,960
+7% +$13.1M
PB icon
36
Prosperity Bancshares
PB
$8.9B
$125M 1.13%
2,596,975
+47,935
+2% +$3.12M
OKTA icon
37
Okta
OKTA
$23.8B
$119M 1.07%
975,900
+231,415
+31% +$29M
JBTM
38
JBT Marel
JBTM
$7.35B
$117M 1.05%
1,574,565
+234,195
+17% +$23.4M
QTWO icon
39
Q2 Holdings
QTWO
$3.78B
$111M 1%
1,879,060
+175,085
+10% +$13.6M
TWNK
40
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$105M 0.94%
9,838,905
-45,395
-0.5% -$576K
ZS icon
41
Zscaler
ZS
$24.9B
$104M 0.93%
+1,702,290
New +$93.7M
WST icon
42
West Pharmaceutical
WST
$23.7B
$97.4M 0.88%
639,730
+23,705
+4% +$3.65M
SNPS icon
43
Synopsys
SNPS
$71.6B
$94.8M 0.85%
736,070
+132,955
+22% +$18.9M
CSII
44
DELISTED
Cardiovascular Systems, Inc.
CSII
$94.7M 0.85%
2,690,410
+292,215
+12% +$12.3M
SXT icon
45
Sensient Technologies
SXT
$5.22B
$93.4M 0.84%
2,147,235
+61,455
+3% +$3.39M
AVNS
46
DELISTED
Avanos Medical
AVNS
$92.5M 0.83%
3,434,370
+100,073
+3% +$2.99M
FRPT icon
47
Freshpet
FRPT
$3.04B
$92.3M 0.83%
1,444,485
+81,715
+6% +$5.25M
CFR icon
48
Cullen/Frost Bankers
CFR
$10.5B
$91.5M 0.82%
1,639,615
+285,165
+21% +$23.2M
TENB icon
49
Tenable Holdings
TENB
$3.47B
$90.8M 0.82%
4,152,475
+264,395
+7% +$6.54M
PBH icon
50
Prestige Consumer Healthcare
PBH
$2.47B
$90.3M 0.81%
2,462,320
+86,915
+4% +$3.38M

Similar funds

Champlain Investment Partners's Q1 2020 Portfolio in Review

As of Q1 2020, Champlain Investment Partners held 128 positions worth $11.1B, down 19% from $13.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Champlain Investment Partners deployed $671M of net new capital in Q1 2020, opening 9 new positions and adding to 85 existing holdings. Its largest new stake was Dunkin' Brands Group, Inc.: 1,501,060 shares worth $79.7M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Teladoc Health, an estimated $122M trimmed.

  • Champlain Investment Partners's largest Q1 2020 buy was Dunkin' Brands Group, Inc.: 1,501,060 shares worth $79.7M.
  • Champlain Investment Partners added most to Medallia, Inc. in Q1 2020, an estimated $127M increase.
  • Champlain Investment Partners's biggest Q1 2020 reduction was Teladoc Health, cutting an estimated $122M.
  • Champlain Investment Partners fully exited Labcorp in Q1 2020, selling an estimated $132M.
  • Champlain Investment Partners's ten largest holdings make up 20% of its $11.1B portfolio in Q1 2020.
  • Champlain Investment Partners opened 9 new positions and closed 9 in Q1 2020.
  • Champlain Investment Partners's portfolio value fell 19% quarter-over-quarter to $11.1B.

Based on Champlain Investment Partners's 13F filing for Q1 2020, filed 14 May 2020.